ABSTRACT
Tumours that occur in the oral cavity may contain granular cells as a component of their pathology. A more common granular cell lesion occurring in the head and neck region is the granular cell tumour (GCT) that usually arises in the tongue or the buccal mucosa. Granular cell tumours are very rare in the parotid gland with only 11 cases previously reported in the English literature. We report a case of a benign tumour involving the parotid gland of a young female patient. The case was diagnostically challenging due to the large proportion of granular cells masking the underlying pathology. Histopathological features and immunohistochemical analysis favoured a diagnosis of a benign GCT. The present report provides an insight into the differential diagnosis and attempts to characterise the granular cells with the use of the wellestablished immunohistochemical markers and conventional histopathological techniques.
INTRODUCTION
Granular cells are characteristic pathological components of many tumours and lesions that occur in the oral cavity. Granular cell odontogenic fibromas, granular cell ameloblastomas, congenital epulis of the newborn (CEN) and oral lichen planus may contain these cells to different extents (1, 2) . The granular cell tumour, originally described by Abrikossof in 1926 is an uncommon benign tumour that may frequently arise in the tongue, skin and subcutaneous tissues (3, 4, 5) . Although very uncommon, a malignant counterpart of GCT has also been described. GCT occurs very rarely in the parotid gland with only 11 cases reported previously in the English-language literature (6) . This report describes in detail the clinicopathologic and immunologic prof ile of a benign parotid gland tumour demonstrating a prominent granular cell change.
Microscopic features:
The tumour was well encapsulated and composed of sheets of granular cells intermingled with spindle cells (Fig. 3) . The granular cells were round to polyhedral with an eosinophilic, coarsely granular cytoplasm and indistinct cell borders. The nuclei ranged from small, dark and hyper chromatic to large with a vesicular chromatin pattern. The nuclei were located either in a peripheral or central location. The spindle cells in the tumour showed an eosinophilic cytoplasm, and a centrally located vesicular nucleus. These cells were arranged in interwoven fascicles at least focally (Fig. 4) . The tumor showed focal areas of cystic degeneration and the granular cells appeared to be related to these degenerating areas. In addition, loosely textured areas akin to myxomatous areas were also observed. Salivary glandular ductal elements were present in an extracapsular location. The granular cells showed faint intra-cytoplasmic Periodic Acid Schiff (PAS) staining after digestion with diastase. Negative staining was observed with Mucicarmine and Alcian blue stains. Immunohistochemical staining demonstrated a strong positive reaction of the lesional cells to CD68 (Fig. 5) and Vimentin (Fig. 6) . The spindle cells demonstrated strong nuclear and cytoplasmic staining to S-100 protein while the granular cells demonstrated only weak cytoplasmic staining (Fig. 7) . Reactivity of the lesional cells to neuron specific enolase (NSE), pancytokeratins, glial fibrillary acidic protein (GFAP), desmin and smooth muscle actin was negative. The source and dilutions used for antibodies are documented in Table 1 . Based on the clinical, histopathological and immunohistochemical features the lesion was diagnosed as a benign granular cell tumour of the parotid gland.
DISCUSSION
Granular cell tumour was originally termed granular cell myoblastoma because the granular cells often appeared to arise from or lie close to skeletal muscle bundles (1, 4) . Ultra structural studies have suggested altered Schwann cells or undifferentiated mesenchymal cells as the cellular origin of this tumor (4) . The membrane bound vacuoles resembling secondary lysosomes that give the cell in GCTs their characteristic granular appearance have been found to resemble myelin ultra-structurally thereby supporting a Schwann cell origin (5) . The histogenesis of GCTs has been the subject of extensive immunohistochemical analysis. S-100 protein is one of the most widely used markers for identification of the granular cells. Traditionally, S-100 antibodies have been proved to be useful in the identif ication of tumours that arise from the neural crest (7). Besides GCTs, positive S-100 staining is observed in melanomas, poorly differentiated carcinomas, peripheral nerve sheath tumors and tumors that contain myoepithelial cells (8) . Granular cell lesions that do not stain with S-100 have been reported by LeBoit et al (9) . They termed these lesions primitive polypoid granular cell tumour and non-neural granular cell tumour (NNGCT) respectively. Lerman and Freedman reported the first intra oral example of an NNGCT. The reported findings in their case were consistent with previous reports in that there was a strong diffuse positivity for NK1-C3 (CD63), Vimentin and negative reactivity for S-100 and NSE (9, 10) .
The monoclonal antibody NK1-C3 (CD63) was initially raised against the gp100 group of glycoproteins present in the cells of melanocytic origin. However it has been observed that positivity to CD63 does not reflect a specific line of cellular differentiation as it has also been demonstrated in degenerating cells and non-melanocytic tumors. Nevertheless this antibody is still regarded as a very sensitive immuno-histochemical marker of granular cell change irrespective of the histogenesis (8). Neuron specific enolase (NSE) is a marker for neural and neuro-endocrine cells. Positive staining with NSE is observed in GCTs but Schwann cells stain negative. This suggested the probability of GCTs being neuroendocrine in origin (5) . Glial fibrillary acidic protein (GFAP) may be seen in a variety of nonglial tumors ranging from pleomorphic adenomas of the salivary glands to pheochromocytomas. Schwann cells and Schwannomas stain for glial fibrillary acidic protein (GFAP), but GCTs are negative. These differences suggested that GCTs may not arise from Schwann cells (5) . Vimentin is ubiquitously expressed by mesenchymal tissues. It is not cell -type specific. Both GCTs and Schwannomas stain positively for vimentin (5, 8) .
Salivary gland neoplasms including mixed tumours, oncocytomas, mucoepidermoid carcinomas, acinic cell adenocarcinomas, polymorphous low grade adenocarcinomas and adenoid cystic carcinomas may commonly contain varying proportions of clear cells. Diagnosis can be challenging when these clear cells constitute the major cellular component. However classification of these tumours would be based on the morphological and histological growth patterns typical of the tumours (11) . The present case did not show any histomorphological evidence of an epithelial neoplasm. Mesenchymal tumours of salivary glands are very rare with a reported incidence ranging from 1.9-5%. Haemangiomas, lipomas and neurogenic tumours are the most common forms of benign tumours involving the salivary glands (12) . Immunohistochemical analysis contributed to our diagnosis as a positive staining with S-100 protein confirmed the neurogenic nature of the lesion in the present case. Presence of a well-defined capsule and lack of inf iltrative characteristics eliminated the possibility of a salivary gland malignancy. The imunohistochemical findings in our case were not characteristic. The spindle cells and the granular cells stained positively for S-100 protein and Vimentin. Although it is popularly believed that S-100 antigen is expressed by all neoplastic Schwann cells, it is known to have a wider distribution and hence may not probably be a reliable marker to establish the neurogenic origin of any lesion (5) . The site of the lesion in our case being the parotid gland and the arrangement of the spindle cells in interlacing fascicles admixed with areas of myxoid degeneration prompted us to include a myoepithelioma in our differential diagnosis. However, the negative immunoreactivity for cytokeratins, glial-fibrillary acidic protein GFAP) and smooth muscle actin ruled out a myoepithelial origin for the lesional cells.
Fibrous histiocytomas in the major salivary glands are rare. They are unencapsulated lesions composed of an admixture of fibroblasts and histiocyte like cells (13) . The presence of short intersecting fascicles of f ibroblast like spindle cells and granular cells resembling foamy histiocytes in our case led to the inclusion of a benign fibrous histiocytoma in our differential diagnosis. However a positive immunoreactivity of the lesional cells for S-100 protein coupled with the presence of a well-defined Source, dilution of antibodies and laboratory procedures for immunostaining employed in the study capsule and absence of any form of giant cells in the present case eliminated this probable diagnosis. A positive diffuse staining was observed with CD-68. Positive immunoreactions to these antibodies may be found in cells of macrophage lineage and occasionally in cells of fibroblastic or Schwannian lineages. CD-68 is organelle specif ic rather than lineage specific. GCTs usually stain positive for CD-68 and it is explained by the assumption that Schwann cells acquire lysosomes during phagocytosis of myelin (8) . The strong positivity of the granular and the spindle cells to CD-68 in the present case may be attributed to their lysosomal content. The accumulation of large numbers of lysosomes within the cells may represent an enzymatic defect in the lysosomes or the synthesis of excessive amounts of myelin material by the tumour cells (14) . Since both the spindle cells and the granular cells were intimately related to each other and demonstrated almost similar immunoreactivity with all the employed markers they may be considered to represent an identical lineage. The granular cells may actually be the manifestation of a metabolic change that was initiated in the spindle shaped Schwann cells.
Granular cell changes have been reported in smooth muscle tumours of skin and soft tissue (14) . Negative immunoreactivity with smooth muscle actin and desmin negated a probable myogenous histogenesis for the lesional cells.
Granular cell reaction is a phenomenon characterized by the accumulation of histiocytes with granular cytoplasm at sites of surgical trauma. These histiocytic reactions bear a close resemblance to GCTs (15) . In 1964 Sobel and Churg def ined simple histologic and histochemical criteria for differentiating granular cell myoblastoma from a granular cell reaction (16). Sobel et al described the reactive granular cells to be acid fast and autofluroscent giving an orangebrown fluorescence. However in our case the granules did not demonstrate these features (Figs. 8 & 9) . A feature that is frequently found in granular cell reaction is accumulation of nodules of granuloamorphous debris similar to the cytoplasmic granular material (15) . The cystic areas associated with the degenerating granular cells within the lesion seen in our case may actually represent the nodules of granulo-amorphous debris described by Sobel et al. However there was no histological evidence of any other significant inflammatory component within the lesion. Ct scans also revealed the persistence of fat spaces within the lesion, a feature that is hardly observed in inflammatory lesions. The only possible inciting factor for a granular cell reaction would have been the fine needle aspiration biopsy performed for the same lesion three years ago.
The present case may be best regarded as a Schwannoma exhibiting granular cell change. Microscopic findings favoring a Schwannoma were encapsulation and arrangement of the spindle cells in whorls and interlacing fascicles (Antoni A areas) alternating with the less orderly and less cellular (Antoni B) areas. Moreover, the lesional cells reacted positively with S-100 protein and Vimentin. The granular cells may represent the degenerative change occurring in a pre-existing Schwannoma but such degenerative cells would not have stained positively for S-100 protein (1). Vimentin staining was diffuse and cytoplasmic in nature. This was in contrast to the distinctive peripheral cytoplasmic reaction pattern in cells of the granular cell tumour. A negative staining with neuron specific enolase (NSE) ruled out a deviant differentiation pattern of the granular cells. The diffuse granular staining pattern with CD-68 highlighted the presence of lysosomes within the lesional cells. Hence we conclude that the present case is a granular cell schwannoma or a benign granular cell tumour (17) .
Further immunostaining with calretinin, alphasubunit of inhibin, PGP9.5, p75/NGFR, Leu-7, MBP, NK1/ C-3, α 1 -antichymotrypsin (AACT) and cathepsin B could be performed to validate the diagnosis of GCT (3, 18, 8) . Calretinin is primarily expressed in certain subtypes of neurons in the central and peripheral nervous systems. Inhibin, a polypeptide hormone consisting of two subunits is secreted primarily by ovarian granulosa cells and sertoli cells. Fine et al demonstrated the usefulness of these two markers in the diagnosis of GCTs (3). Mazur et al reported reactivity of GCTs to AACT and cathepsin B which are histiocytic markers. The presence of these two markers in GCTs has been related to the formation of many phagolysosomes in these tumours (18) . The protein gene product 9.5 (PGP9.5) has a wide spectrum of distribution including neuronal and neuroendocrine cells and has been found to be expressed in GCTs. p75 immunoreactivity has been reported in a large group of fetal and adult tissues as well as in neural, non-neural and oral granular cell tumours (8) . Myelin basic protein (MBP) and Leu-7, markers for myelin glycoprotein have been demonstrated in GCTs (18) .
The present case is reported to highlight the variable histomorphologic and staining patterns of the lesional cells. The location of the tumor coupled with the uncertainty regarding the histogenesis of the granular cells added to the difficulty in establishing a final diagnosis. Cytoplasmic granularity has been observed in cells from a variety of conditions that include benign and malignant tumours and reactive lesions. We confer with the views of Vered et al that the appearance of granular cells is not limited to one cell type and the cell of origin may differ according to its accessibility at any site (8) .
In regards to the present case the granular change may be considered as an expression of a metabolic change in the Schwann cells since a reactive pathogenesis could not be established and hence may not warrant consideration as a distinct histopathological entity. 
